Fig. 5 | Scientific Reports

Fig. 5

From: Effect of trimetazidine on left ventricular functions and cardiac biomarkers in diabetic patients with left ventricular diastolic dysfunction: a randomized controlled trial

Fig. 5

Change in diastolic function parameters after 3 months of intervention in TMZ and placebo groups. Data are presented as mean ± 2 standard error. E/A: peak early to late trans-mitral flow velocity. LAVI: left atrial volume index. e’: peak early diastolic velocity of mitral annular motion. #p < 0.05 vs baseline. * p < 0.05 vs placebo group.

Back to article page